The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 11 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Givoly: WebMD's information is static and fails to reflect new research
“WebMD's information is essentially fairly static. There's a page about lymphoma and about treatment options, but it doesn't get updated every research paper that gets updated.”
Givoly: Biopharma will eventually become Medivisor's largest revenue stream
“So, ultimately, over time, it's going to be, ah, basically, ah, the biopharma is gonna be larger.”
Givoly: Medivisor revenue is split fifty-fifty between licensing and biopharma
“Today it's about fifty-fifty.”
Givoly: Medivisor has over 130,000 subscribers across 129 countries
“We're, by the way, helping over 130,000 subscribers. In a 129 countries, though the vast majority are in the US.”
Givoly: Medivisor's clinical trial acceleration deals are six-figure contracts
“It's usually bigger, longer deals to longer term engagement. So, for example, a clinical trial that wants to be accelerated, it could be a six-figure deal to work with us to help accelerate that trial.”
Givoly: Medivisor's last four biopharma deals closed inbound within three months
“So far, the interesting thing is that the last four deals have come to us and closed within three months. So without us even meeting them. So yeah, we had phone conversations and so on, but the last deals have actually discovered us online found out that we co…”
Givoly: Leukemia & Lymphoma Society licenses Medivisor's content
“The Leukemia Lymphoma Society, they have an online community that they're trying to cultivate. They sponsor blood cancer as a med advisor, and they license the content that we provide so that we could feed it into their community members.”
Givoly: Co-founder Oren Fierst previously founded over 10 health-tech companies
“He started over 10 other health tech companies.”
Givoly: Medivisor has a core team of six to seven full-time staff
“No, no, we don't have 35 full-time staff. It's all, most of the team is part-time, there's a core of about six, seven people full-time.”